Ms. magazine  -- more than a magazine a movement

SIGN UP FOR MS. DIGEST, JOBS, NEWS AND ALERTS

FEMINIST WIRE NEWSBRIEFS

ABOUT
SEE CURRENT ISSUE
SHOP MS. STORE
MS. IN THE CLASSROOM
FEMINIST DAILY WIRE
FEMINIST RESOURCES
PRESS
JOBS AT MS.
READ BACK ISSUES
CONTACT
RSS (XML)
 
feminist wire | daily newsbriefs

June-16-99

Osteoporosis Drug Decreases Risk for Breast Cancer

According to a study published in The Journal of the American Medical Association, a new drug being tested to combat osteoporosis in premenopausal women has been found to simultaneously fight breast disease. An international study conducted in 180 American hospitals and 24 European health centers found that raloxifene reduced a womanís risk of contracting breast cancer by 76%.

The 3-year breast cancer study followed 7,705 women; 2,557 who received one tablet of raloxifene per day, 2,572 who took two raloxifene pills daily, and 2,576 women who took two placebo pills each day. All the women were under 81 years of age.

Results showed that of the women who received either dose of raloxifene (5,129 women), only 13 cases of breast cancer developed. This compares to 26 cases of breast cancer found in the women who took the dummy pills (2,576 women).

Researchers report that raloxifene "prevents estrogen-related breast cancers by occupying the same molecular receptor sites as the estrogen molecule on the surface of cells. [It] blocks estrogen's cancer promoting effects on breast and endometrial tissue . . ." Scientists are comparing this drug with tamoxifen, a similar drug that also obstructs estrogen on breast tissue.

Side effects of raloxifene included blood clots, hot flashes, flu symptoms, cramps, and swelling of the legs. The results of the study found no differences in the effectiveness of the drug in women who received one or two tablets of raloxifene daily. Currently, the study is continuing in order to examine the long-term effects and usefulness of raloxifene in preventing breast cancer.

Media Resources: New York Times - June 16, 1999


© Feminist Majority Foundation, publisher of Ms. magazine

If you liked this story, consider making a tax-deductible donation to support Ms. magazine.

 

 

Send to a Friend
Their
Your
Comments
(optional)


More Feminist News

1/27/2016 Study Exposes 'Gender Gap' in Media Coverage of Reproductive Issues - A new study by the Women's Media Center has revealed more than half of news stories focusing on reproductive issues are written by men. According to WMC Media Watch: the Gender Gap in Coverage of Reproductive Issues, men penned 52 percent of bylines discussing issues of reproductive health care - including contraception and abortion - compared to just 37 percent by women. . . .
 
1/27/2016 Taiwan Elects First Woman President - In a landslide victory, the leader of Taiwan's Democratic Progressive Party (DPP) Tsai Ing-wen won the country's presidential election, becoming the first woman in Taiwan's history to hold the position. Emphasizing her party's commitment to maintaining Taiwan's independence from China, Tsai won over young voters eager to usher in a political changing of the guard following some 70 years of dominance by the pro-Chinese unification party, the Kuomintang (KMT), chaired by presidential opponent Eric Chu. . . .
 
1/26/2016 Anti-Abortion Extremists Behind Planned Parenthood Attack Videos Indicted - Two anti-abortion extremists responsible for last year's misleading videos attacking Planned Parenthood have been indicted on criminal charges by a grand jury in Houston, Texas. On Monday, Harris County district attorney Devon Anderson announced that David Daleiden, the director of the Center for Medical Progress (CMP) - the group behind deceptive videos falsely accusing Planned Parenthood of illegally selling fetal tissue - was indicted on a felony charge of tampering with a governmental record and on a misdemeanor charge related to the purchasing of human organs. . . .